Adagio Medical Holdings, Inc Common Stock (ADGM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Adagio Medical Holdings, Inc Common Stock (ADGM) has a cash flow conversion efficiency ratio of 2.293x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.01 Million) by net assets ($-1.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Adagio Medical Holdings, Inc Common Stock - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Adagio Medical Holdings, Inc Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ADGM total debt and obligations for a breakdown of total debt and financial obligations.
Adagio Medical Holdings, Inc Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Adagio Medical Holdings, Inc Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rubean AG
F:R1B
|
N/A |
|
Gillanders Arbuthnot & Company Limited
NSE:GILLANDERS
|
0.009x |
|
Elevation Oncology Inc
NASDAQ:ELEV
|
-0.272x |
|
Archtis Ltd
AU:AR9
|
-0.252x |
|
Nyesa Valores Corp SA
MC:NYE
|
-0.331x |
|
Ocean Vantage Holdings Bhd
KLSE:0220
|
-0.192x |
|
MIND CTI Ltd
NASDAQ:MNDO
|
0.053x |
|
NanoViricides Inc
NYSE MKT:NNVC
|
-0.222x |
Annual Cash Flow Conversion Efficiency for Adagio Medical Holdings, Inc Common Stock (2021–2024)
The table below shows the annual cash flow conversion efficiency of Adagio Medical Holdings, Inc Common Stock from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Adagio Medical Holdings, Inc Common Stoc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $19.91 Million | $-29.46 Million | -1.479x | -861.43% |
| 2023-12-31 | $-132.02 Million | $-25.65 Million | 0.194x | -16.88% |
| 2022-12-31 | $-95.88 Million | $-22.41 Million | 0.234x | -12.08% |
| 2021-12-31 | $-72.62 Million | $-19.31 Million | 0.266x | -- |
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablat… Read more